why would anyone bother to “tap into … IMU’s shareholder base”?!?!? The current IMU shareholders are losing money and poor pickers of biotechs. They are also likely holders or previously holders of PH’s other turkeys (or is it Christmas goose/geese) CHM and RAD. Again losing heaps of money and proving to be poor pickers of biotechs.
PH and his followers don’t pick winners and loser in the ASX biotech industry …. They just pick the losers (IMU, CHM, RAD).
Current IMU holders (as opposed to the ex-holders of IMU who sold at previous highs) have a reduced portfolio (up to a loss of 95% over last 3 years) in which to buy other stocks and a poor ability to time their biotech buys and sells.
if anything RAC will be tapping the successful ASX biotechs … CU6, TXL and NEU. But you don’t see any RAC holder saying anything negative about those stocks, because we are likely also holders of those successful biotechs too.
IMU Price at posting:
3.8¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)